HER2 (synonym: ErbB2) is a cell-surface receptor with a transmembrane tyrosine kinase domain that plays a crucial role in tumor biology through the downstream activation of the PI3K/Akt pathway (call polarity, cell adhesion, cell cycle) and the MAPK pathway (mitosis) in multiple cancers [90,91]. This evidence concerns the gene AKT1 and neoplasm.